down arrow

Tenet Healthcare Corp.

  • Market Cap: Mid Cap
  • Industry: Hospital
  • ISIN: US88033G4073
USD
212.14
0.8 (0.38%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

209.56212.97

52 Week

109.82222.00
Valuation
Technical
Day's Volume

CASH

254.22 k

Shareholding (Mar 2025)

FII

12.52%

Held by 239 FIIs

DII

32.25%

Held by 67 DIIs

Promoter

0.52%

How big is Tenet Healthcare Corp.?

22-Jun-2025

As of Jun 18, Tenet Healthcare Corp. has a market capitalization of $23.65 billion, with net sales of $20.52 billion and a net profit of $2.35 billion over the latest four quarters. The balance sheet shows shareholder's funds of $4.17 billion and total assets of $28.94 billion.

As of Jun 18, Tenet Healthcare Corp. has a market capitalization of 23,648.40 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the company reported net sales of 20,520.00 million and a net profit of 2,352.00 million for the latest four quarters.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 4,171.00 million and total assets amounting to 28,936.00 million.

Read More

What does Tenet Healthcare Corp. do?

22-Jun-2025

Tenet Healthcare Corporation is a mid-cap diversified healthcare services company primarily operating in the hospital industry, with recent net sales of $5.2 billion and a net profit of $622 million. The company has a market cap of $23.6 billion and key metrics include a P/E ratio of 10.00 and a return on equity of 59.01%.

Overview:<BR>Tenet Healthcare Corporation is a diversified healthcare services company operating in the hospital industry within the mid-cap market.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 5,223 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 622 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 23,648.40 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 10.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 2.43 <BR>Return on Equity: 59.01% <BR>Price to Book: 5.66<BR><BR>Contact Details:<BR>Address: 14201 DALLAS PARKWAY, DALLAS TX: 75254 <BR>Tel: 1 469 8932200 <BR>Website: https://www.tenethealth.com/

Read More

Who are in the management team of Tenet Healthcare Corp.?

22-Jun-2025

As of March 2022, Tenet Healthcare Corp.'s management team includes Mr. Ronald Rittenmeyer as Executive Chairman and CEO, and Dr. Saumya Sutaria as President and COO. The Board of Directors features independent members such as Adm. Cecil Haney and Gen. Lloyd Austin.

As of March 2022, the management team of Tenet Healthcare Corp. includes the following key individuals:<BR><BR>- Mr. Ronald Rittenmeyer, who serves as the Executive Chairman of the Board and Chief Executive Officer.<BR>- Dr. Saumya Sutaria, who holds the positions of President, Chief Operating Officer, and Director.<BR><BR>Additionally, the Board of Directors includes Adm. Cecil Haney, Gen. Lloyd Austin, Mr. James Bierman, Mr. Richard Fisher, and Ms. Meghan FitzGerald, all of whom are independent directors.

Read More

Is Tenet Healthcare Corp. technically bullish or bearish?

20-Sep-2025

As of August 26, 2025, Tenet Healthcare Corp. is in a bullish trend supported by strong MACD and moving averages, despite a mildly bearish KST signal, and has significantly outperformed the S&P 500 with a year-to-date return of 50.75%.

As of 26 August 2025, the technical trend for Tenet Healthcare Corp. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, and moving averages are bullish on a daily basis. Additionally, the Dow Theory confirms a bullish trend on both weekly and monthly levels. However, the KST shows a mildly bearish signal on both time frames, indicating some caution. <BR><BR>In terms of performance, Tenet Healthcare has outperformed the S&P 500 over multiple periods, with a year-to-date return of 50.75% compared to the S&P 500's 12.22%, and a three-year return of 222.31% versus 70.41% for the benchmark.

Read More

Is Tenet Healthcare Corp. overvalued or undervalued?

28-Oct-2025

As of October 24, 2025, Tenet Healthcare Corp. is fairly valued with a P/E ratio of 10, an EV to EBITDA ratio of 8.89, and a high ROE of 59.01%, while outperforming the S&P 500 with a return of 39.24% over the past year.

As of 24 October 2025, the valuation grade for Tenet Healthcare Corp. has moved from expensive to fair. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 10, while the EV to EBITDA ratio is 8.89 and the Price to Book Value is 5.79. <BR><BR>In comparison to its peers, Tenet Healthcare Corp. has a P/E ratio of 10.41 and an EV to EBITDA ratio of 9.11, indicating that it is competitively positioned within the industry. Notably, the company's ROE is exceptionally high at 59.01%, suggesting strong profitability relative to shareholder equity. Over the past year, Tenet has outperformed the S&P 500 with a return of 39.24% compared to the index's 16.90%, reinforcing the notion that the stock is fairly valued given its performance.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Jun 25

  • NET PROFIT(HY) At USD 765.55 MM has Grown at -68.97%
2

With ROCE of 21.26%, it has a very expensive valuation with a 2.40 Enterprise value to Capital Employed

3

Consistent Returns over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 26,308 Million (Mid Cap)

stock-summary
P/E

10.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.81

stock-summary
Return on Equity

67.40%

stock-summary
Price to Book

7.02

Revenue and Profits:
Net Sales:
5,271 Million
(Quarterly Results - Jun 2025)
Net Profit:
522 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.19%
0%
10.19%
6 Months
24.87%
0%
24.87%
1 Year
49.91%
0%
49.91%
2 Years
193.38%
0%
193.38%
3 Years
368.51%
0%
368.51%
4 Years
198.58%
0%
198.58%
5 Years
513.48%
0%
513.48%

Tenet Healthcare Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Tenet Healthcare Corp. Hits New 52-Week High at $217.43

Tenet Healthcare Corp. Hits New 52-Week High at $217.43

Tenet Healthcare Corp. achieved a new 52-week high on October 24, 2025, reflecting strong performance in the hospital industry with a one-year gain of 52.71%. The company, with a market cap of USD 26,308 million, demonstrates effective management and profitability, despite a higher debt-to-equity ratio.

Read More
Tenet Healthcare Corp. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance

Tenet Healthcare Corp. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance

Tenet Healthcare Corp. has recently adjusted its valuation, with its stock price at $210.38. Over the past year, the company has delivered a 39.24% return, significantly surpassing the S&P 500. Key financial metrics indicate strong performance, including a P/E ratio of 10 and a return on equity of 59.01%.

Read More

Is Tenet Healthcare Corp. overvalued or undervalued?

As of 24 October 2025, the valuation grade for Tenet Healthcare Corp. has moved from expensive to fair. Based on the analysis, the company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 10, an EV to EBITDA of 8.89, and a Price to Book Value of 5.79. In comparison, its peer, which has a P/E of approximately 10.41 and an EV to EBITDA of 9.11, suggests that Tenet is in line with industry standards. Tenet Healthcare Corp. has demonstrated strong performance with a year-to-date return of 66.66%, significantly outperforming the S&P 500's return of 15.47% over the same period. This robust performance reinforces the notion that the stock is fairly valued given its current metrics....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
3.35%
EBIT Growth (5y)
21.00%
EBIT to Interest (avg)
2.62
Debt to EBITDA (avg)
4.05
Net Debt to Equity (avg)
2.43
Sales to Capital Employed (avg)
1.23
Tax Ratio
19.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
16.26%
ROE (avg)
318.48%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
5.79
EV to EBIT
11.27
EV to EBITDA
8.89
EV to Capital Employed
2.40
EV to Sales
1.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.26%
ROE (Latest)
59.01%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 125 Schemes (54.7%)

Foreign Institutions

Held by 239 Foreign Institutions (12.52%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.92% vs 2.98% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -16.08% vs 8.74% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,271.00",
          "val2": "5,223.00",
          "chgp": "0.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,060.00",
          "val2": "1,107.00",
          "chgp": "-4.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "206.00",
          "val2": "204.00",
          "chgp": "0.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-52.00",
          "val2": "-36.00",
          "chgp": "-44.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "522.00",
          "val2": "622.00",
          "chgp": "-16.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "161.60%",
          "val2": "172.50%",
          "chgp": "-1.09%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.57% vs 7.17% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 209.99% vs 31.10% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20,665.00",
          "val2": "20,548.00",
          "chgp": "0.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,725.00",
          "val2": "3,297.00",
          "chgp": "12.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "826.00",
          "val2": "901.00",
          "chgp": "-8.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-135.00",
          "val2": "-195.00",
          "chgp": "30.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,064.00",
          "val2": "1,311.00",
          "chgp": "209.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "140.70%",
          "val2": "118.10%",
          "chgp": "2.26%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
5,271.00
5,223.00
0.92%
Operating Profit (PBDIT) excl Other Income
1,060.00
1,107.00
-4.25%
Interest
206.00
204.00
0.98%
Exceptional Items
-52.00
-36.00
-44.44%
Consolidate Net Profit
522.00
622.00
-16.08%
Operating Profit Margin (Excl OI)
161.60%
172.50%
-1.09%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.92% vs 2.98% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -16.08% vs 8.74% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
20,665.00
20,548.00
0.57%
Operating Profit (PBDIT) excl Other Income
3,725.00
3,297.00
12.98%
Interest
826.00
901.00
-8.32%
Exceptional Items
-135.00
-195.00
30.77%
Consolidate Net Profit
4,064.00
1,311.00
209.99%
Operating Profit Margin (Excl OI)
140.70%
118.10%
2.26%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 0.57% vs 7.17% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 209.99% vs 31.10% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Tenet Healthcare Corp. stock-summary
stock-summary
Tenet Healthcare Corp.
Hospital
Tenet Healthcare Corporation is a diversified healthcare services company. The Company’s segments include Hospital Operations and other (Hospital Operations) segment, Ambulatory Care segment and Conifer segment. Through its subsidiaries, partnerships and joint ventures, including USPI Holding Company, Inc. (USPI), The Company operates approximately 65 hospitals and more than 520 other healthcare facilities, including ambulatory surgery centers, urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments and micro-hospitals. In addition, it operates Conifer Health Solutions, LLC through its Conifer Holdings, Inc. (Conifer) subsidiary, which provides revenue cycle management and value-based care services to hospitals, healthcare systems, physician practices, employers and other customers.
Company Coordinates stock-summary
Company Details
14201 DALLAS PARKWAY , DALLAS TX : 75254
stock-summary
Tel: 1 469 8932200
stock-summary
https://www.tenethealth.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."